Artemisinin-induced dormancy is a proposed mechanism for failures of monotherapy and is linked with artemisinin resistance in Plasmodium falciparum. The biological characterization and dynamics of dormant parasites are not well understood. Here we report that after dihydroartemisinin treatment in vitro, a small subset of morphologically dormant parasites was stained with rhodamine 123 (RH), a mitochondrial membrane potential marker, and persisted to recovery. RH-positive parasites sorted with fluorescence-activated cell sorting resumed growth at 10 000/well whereas RH-negative parasites failed to recover at 5 million/well. Furthermore, transcriptional activity for mitochondrial enzymes was detected only in RH-positive dormant parasites. Importantly, after treatment of dormant parasites with different concentrations of atovaquone, a mitochondrial inhibitor, the recovery of dormant parasites was delayed or stopped. This demonstrates that mitochondrial activity is critical for survival and regrowth of dormant parasites and that RH staining provides a means of identifying these parasites. These findings provide novel paths for studying and eradicating this dormant stage.
Artemisinin-based combination therapies are the frontline treatment for uncomplicated Plasmodium falciparum malaria, and their use has contributed to the worldwide reduction of malaria incidence rates [1, 2] . Before recent reports of emerging resistance to artemisinins [3] [4] [5] [6] , evidence showed that up to 50% of patients experienced treatment failures after artemisinin monotherapy, despite sensitivity of parasites to artemisinin class compounds [7] . Antimalarial combinations have significantly reduced the rate of recrudescence.
Understanding the mechanisms underlying frequent recrudescence after artemisinin monotherapy and increasing the efficacy of combination therapies will greatly improve future treatments.
Recently, treatment failure has been attributed to artemisinin-sensitive ring-stage parasites entering growth arrest, referred to as dormancy [8, 9] , after artemisinin monotherapy and resuming growth several days later. Artemisinin-induced dormancy has been observed in vitro [9] [10] [11] , as well as in vivo in a mouse malaria model [12] . Proposed to be a stress response that helps parasites survive artemisinin pressure [13] , dormancy is linked to the ability of parasites to recover from artemisinin treatment at concentrations up to 7000 times the initial median inhibitory concentration for up to 96 hours [11] . Teuscher et al [14] demonstrated that decreases in the number of parasites entering the dormant phase may be an indicator of the parasite line's acquiring resistance to artemisinin. Similar findings were reported in another laboratory-generated artemisinin-resistant line [11] and also in artemisinin-resistant field isolates, as increasing ring survival rates [15] . These studies indicate that dormancy is linked with an artemisinin resistance phenotype, and understanding how parasites initiate and maintain the dormant state is important in combatting artemisinin resistance.
Although the phenomenon of dormancy is accepted, there are conflicting views about the morphological characteristics of dormant parasites. Teuscher et al [9] and Tucker et al [10] described dormant parasites, similar to the collapsed nuclei of pyknotic forms, retaining some blue cytoplasm and condensed red chromatin; these are morphologically distinct from typical ring-stage parasites. Witkowski et al [16] reported that after treatment with 700 nmol/L dihydroartemisinin (DHA), the morphologically normal-looking ring-stage parasites underwent cell cycle arrest and maintained a ring shape for up to 48 hours. Establishing a biomarker will help identify dormant parasites and assist investigations into the mechanism of dormancy.
The dormancy phenomenon is not uncommon in microorganisms. Saccharomyces cerevisiae enters a dormant phase during periods of unfavorable growth conditions, when cells stop glycolysis and start metabolizing ethanol through the tricarboxylic acid (TCA) cycle [17] . Recent studies show that mutant yeast species, deficient in genes encoding proteins used for oxidative phosphorylation and other mitochondrial functions, fail to survive the dormant phase [18] . This indicates that mitochondria are vital to the maintenance of yeast cells when they enter the dormant phase.
The mitochondria of malaria parasites differ from other eukaryotic cells. They are present in all stages, including the ring stage, and share a close association with the apicoplast [19] . The proximity of these organelles has been hypothesized as necessary for metabolic interaction [19, 20] . The malarial mitochondrion is involved in metabolic pathways including pyrimidine biosynthesis, iron-sulfur cluster and heme biogenesis, the biosynthesis of ubiquinone, and TCA metabolism [21] . Chen et al [22] recently reported that both the apicoplast and mitochondrion remain active in dormant rings, suggesting an important role for these organelles in the survival and recovery of dormant parasites.
To confirm that dormant parasites maintain some mitochondrial function and determine whether this could be used as a biomarker, we used a mitochondrial dye, rhodamine 123 (RH), to detect and characterize the morphological features and dynamics of dormant parasites. RH binds to the mitochondrial membrane of cells and is an indicator of mitochondrial membrane potential (MMP), essential for mitochondrial function and thus cell viability. Mitochondrial activity has been measured with RH in another apicomplexan, Toxoplasma gondii [23] . RH has been used to identify live P. falciparum parasites with flow cytometry [24] [25] [26] [27] and to show that parasites treated with antimalarial drugs lost RH staining and never resumed growth [25] .
Here we report that after DHA treatment in vitro, a small subset of morphologically dormant parasites was stained with RH, and only RH-stained parasites resumed growth. Furthermore, transcriptional activity of mitochondrial enzymes was detected only in RH-positive dormant parasites. Importantly, after treating dormant parasites with atovaquone (ATQ), a mitochondrial inhibitor, we successfully delayed the recovery of dormant parasites. This demonstrates that mitochondrial activity is critical for survival and regrowth of dormant parasites. RH staining can be used to distinguish dormant from dead parasites in DHA-treated cultures. These findings provide novel methods for studying and eradicating dormant parasites.
METHODS

Parasite Cultivation
Plasmodium falciparum strain W2 (Indochina) was cultivated using standard techniques in Roswell Park Memorial Institute 1640 HEPES (Sigma Aldrich) culture medium supplemented with 10% human plasma and at 3% hematocrit [28] . Before each experiment, parasites were synchronized at the ring stage using 2 rounds of 5% D-sorbitol treatment [29] .
Induction and Selection of Dormant Parasites
Synchronized ring-stage parasites were treated with 200 ng/mL DHA (Sigma Aldrich) for 6 hours and then washed with culture medium. The treated culture was passed through a magnetic column (25 magnetic-activated cell sorting CS separation columns; Miltenyi Biotec) on days 1-3, as described elsewhere [9] . Parasite samples were collected before and daily after DHA treatment in investigations detailed below. In experiments using day 2 posttreatment parasites, approximately 50% of parasites were morphologically dormant and remaining parasites were dead [22] . Ring-stage W2 parasites were treated with ATQ (61 µmol/L, for 24 hours)-a known inhibitor of cytochrome b-c 1 complex-that results in a loss MMP.
Investigating Dynamics of RH-and SYBR Green-Stained Parasites After DHA Treatment After DHA, or ATQ treatment, a daily sample (100 µL) was stained with either RH (Sigma Aldrich) at 10 µg/mL or SYBR Green (SG; ×10 000 concentration; Sigma Aldrich) diluted to ×20 concentration, as described elsewhere [26, 30] , for flow cytometric analysis. Thin blood smears were Giemsa stained and examined with microscopy.
For fluorescence-activated cell sorting (FACS) analysis, parasites were washed 3 times in ×1 phosphate-buffered saline (PBS) and then analyzed with a FACS Canto II cell sorter (Becton Dickson) using the 488 nmol/L blue laser to determine RH-or SG-stained fraction. Flow cytometric data, collected from 100 000 events, were analyzed using FlowJo software (Tree Star). Stained uninfected red blood cells (controls) were gated out and referred to as RH-negative or SG-negative fractions and subtracted from treatment samples. All other fluorescence events were considered RH-positive or SG-positive events. The experiment was repeated 3 times using different cultures.
Investigating Recovery of RH-and SG-Stained and Unstained Parasites
On day 2 after DHA treatment, parasites were stained with RH, resuspended in ×1 PBS and sorted using a FACS Aria live cell sorter (Becton Dickson). Both RH-positive and RH-negative fractions were collected. The RH-negative fractions were subsequently stained with SG and resorted (RH negative/SG positive). Both RH-positive and RH-negative/SG-positive parasites were then plated out in 96-well plates in triplicate, containing 10 000, 1000, 100, and 10 sorted parasites per well. A culture containing RH-negative/SG-positive parasites at 5 000 000/ well was also included. Plates were washed in PBS and returned to culture conditions. Parasites were monitored every 96 hours by microscopy and counted with RH and SG, using a FACS Canto II cell sorter with the high-throughput sampler option, to detect parasite growth for 25 days or until they reached 10% parasitemia. The experiment was repeated 3 times.
Investigating Micrographs of Dormant Parasites
An aliquot of RH-positive and RH-negative/SG-positive parasites sorted on day 2 after DHA treatment was Geimsa stained and examined with light microscopy. Parasite images were captured with a Jenoptik Progress C14 camera system (Jenoptik) operating Image-Pro software.
Investigating Mitochondrial and Apicoplast Gene Transcription
A total of 20 000 RH-positive untreated ring-stage parasites and 20 000 each of RH-positive, RH-negative/SG-positive DHAtreated ring-stage parasites (day 2 after treatment) were used to measure transcription of mitochondrial enzymes. RNA isolation and complementary DNA synthesis were performed as described elsewhere [22] . Transcriptions of 3 genes encoding mitochondrial enzymes, including cytochrome c oxidase subunit II (coxii), flavoprotein subunit of succinate dehydrogenase (sdha) and ubiquinnol-cytochrome c reductase iron-sulfur subunit (uqcr), and 2 genes encoding apicoplast enzymes, lipoyl synthase (lipA) and biotin carboxylase subunit of acetyl coenzyme A carboxylase (bc), were examined with real-time quantitative polymerase chain reaction using gene-specific primers, and results were normalized as described elsewhere [22] . Triplicate samples from 3 sorts (n = 3 × 3 = 9) were analyzed, and the mean quantification cycle (Cq value) was calculated. These values were compared with those of 20 000 untreated RH-positive parasites to provide a relative proportion for 20 000 DHA-treated RH-positive and RH-negative/SG-positive parasites.
Investigating Dynamics of RH-and SG-Stained Parasites After Exposure to Other Artemisinin Derivatives
Parasites were treated with artelenic acid (ARTA) (200 ng/mL) or artesunate (AS) (200 ng/mL) for 6 hours and monitored daily with FACS using both RH and SG staining, as described above.
Investigating Effects of a Mitochondrial Inhibitor on DHAInduced Dormancy
W2 parasites were treated with DHA (200 ng/mL) for 6 hours and subsequently, 24 hours after initiation of treatment, were exposed to 3 concentrations of ATQ, 3 nmol/L (90% inhibitory concentration [IC 90 ]), 30 nmol/L (×10 IC 90 ), and 300 nmol/L (×100 IC 90 ) for 24 hours. Parasite recovery was monitored using RH staining analyzed with FACS, compared with parasites treated with DHA alone.
RESULTS
Dynamics of RH-Positive and SG-Positive Parasites After DHA Treatment
Before DHA treatment the mean (standard deviation [SD]) proportions of RH-and SG-stained parasites were 2.9% (0.09%) and 3.1% (0.03%), respectively. RH-positive parasites averaged 94% of the SG-stained parasites, indicating that the majority of parasites have MMP.
After exposure to DHA the number of SG-positive parasites remained unchanged (mean [SD], 3.1% [0.03%]) during the first 24 hours, followed by a slight decline to 2.3% (0.07%) (74.8% of pretreatment) 48 hours after treatment ( Figure 1A) . SG-positive parasites decreased to 1.0% (0.05%) (33.7% of pretreatment) at 72 hours and further dropped to a mean of 0.04% (1.6% of pretreatment) from day 4 until day 12. SGpositive parasite counts increased after day 12, reaching 10% at day 17 (0.3) (mean [SD]) ( Figure 1A) .
In contrast, RH-positive parasite density decreased rapidly from a mean pretreatment parasite density of 2.9% (SD, 0.09%) to 0.1% (0.01%) (3.5% of pretreatment) at 24 hours and then declined to 0.03% (0.01%) (1.2% of pretreatment) at 48 hours ( Figure 1A) . The RH-positive parasite fraction remained at this level between days 2 and 12 after treatment, averaging 0.02%, which is 0.9% of the total treated parasite population. This indicates that a very small proportion (<1%) of DHA-treated parasites maintained MMP from day 2 through day 12. The RH-positive parasite count started to increase after day 12, reaching 10% parasitemia at a mean of 16.67 (0.33) days (3 experiments) ( Figure 1A) .
As expected, the ratio of RH-positive to SG-positive parasites decreased markedly (from 93.8% to 3.3%) 24 hours after DHA treatment (Figure 2 ). This ratio was maintained at a mean of 2.7% between days 1 and 3 and then increased to 52.2% between days 4 and 12. These data indicate that among the very small proportion of parasites stained by SG (approximately 1.5% of pretreatment), approximately 50% maintained MMP from 4 to 12 days after DHA treatment. The ratio recovered to pretreatment levels on day 17, indicating that the majority of parasites have MMP similar to pretreatment parasites.
Dynamics of RH-Positive and SG-Positive Parasites After ATQ Treatment
After ATQ treatment, SG-positive parasite density remained unchanged in the first 24 hours and declined to approximately 50% at 72 hours after treatment ( Figure 1B) . In contrast, RH-positive parasite density decreased rapidly to 0.00% at 72 hours. Unlike after DHA treatment, no persisting RH-positive-stained parasites were detected beyond 72 hours after ATQ treatment, and the culture had not recovered when monitoring ceased at day 25.
Dynamics of RH-positive and SG-positive Parasites After Exposure to Other Artemisinin Derivatives
Both ARTA and AS treatments generated similar dynamic patterns to DHA treatment, with a small persisting proportion of RH-positive parasites recovering to 10% in 19 and 21 days, respectively. The mean (SD) density of RH-positive parasites after ARTA and AS treatment was 0.1% (0.02%) from day 5 until day 16 and 0.1% (0.01%) from day 2 until day 15, respectively, when recovery started. (Figure 1C and 1D) . The RH-positive parasites constituted 1.3% and 1.0% of the ARTA and AS parasites, respectively. Figure 3A shows that RH-positive parasites, sorted on day 2 after DHA treatment, conform with the morphological features identified by Teuscher et al [9] and Tucker et al [10] , showing blue cytoplasm and condensed red chromatin. In contrast, the RH-negative/SG-positive parasites have collapsed nuclei without cytoplasm. Compared with untreated rings, dormant rings have both compact nuclei (stained by SG) and mitochondria (stained by RH) ,consistent with the description by Tucker et al [10] (Figure 3B ).
Micrographs of RH-Positive Parasites
Recovery of RH-Positive Parasites
To demonstrate the viability of parasite populations, FACSsorted RH-positive and RH-negative/SG-positive parasites were serially diluted and cultured until parasitemia reached 10% or until day 25 after treatment. Parasite growth was observed in all wells containing RH-positive parasites plated at 10 000/well but not in any other cultures (Table 1) . At 25 days after treatment the 10 000/well culture reached 10% parasitemia. These results were reproduced in all 3 experiments.
Transcription of Mitochondrial and Apicoplast Genes in RH-Sorted Parasites
Transcription levels of 6 genes from major metabolic pathways involving the mitochondria and apicoplast and a control uninfected erythrocytes) . B, Fluorescent images of Plasmodium falciparum rings before and after treatment with dihydroartemisinin (DHA). Ring-stage parasites (after sorbitol treatment) were treated with either and RH or SG, and images were obtained. For DHA-treated parasites, images were obtained on day 2 after treatment.
housekeeping gene (sars) were determined in both RH-positive and RH-negative/SG-positive parasites. In RH-positive parasites, post-DHA treatment transcription levels of sars were reduced to very low levels compared with untreated rings. In contrast, although the transcription levels of the genes involved in the mitochondrial electron transport chain, coxii, sdha, and uqcr were all reduced compared with untreated rings, they were much higher than those for sars, maintaining above 15% of untreated rings (Figure 4) . The apicoplast gene involved in fatty acid synthesis, bc, had transcription levels 176.5% of that observed in untreated rings, and the gene involved in the lipoic acid metabolism, lipA, had transcription levels of 61.9% of untreated rings (Figure 4) . No transcription was detected for any of these 6 genes in the same number of RH-negative/SG-positive parasites. This suggests that the mitochondria/apicoplast complex was active in RH-positive DHA-treated parasites but not in RH-negative/SG-positive parasites.
Effect of Atovaquone on DHA-Induced Dormant Parasites
Four combination treatments of DHA/ATQ were tested to see if regrowth could be curtailed ( Figure 5 ). When ATQ was added after DHA at the IC 90 level, the time for parasite recovery to 3% parasitemia was 1 day longer than for DHA alone. Parasite recovery was further delayed by 6 days when the ATQ concentration was at the ×10 IC 90 level. There was no parasite recovery at 25 days when the ATQ concentration was ×100 IC 90 .
DISCUSSION
There is growing evidence that parasites enter a state of dormancy after treatment with artemisinin class drugs and a small proportion resume growth, probably causing the clinical recrudescence reported in the field [7] . However, apart from demonstrating parasites recovering after artemisinin treatment [9] , direct evidence showing live dormant parasites and their dynamics has not been presented. There is also no reliable method of identifying dormant parasites. Evidence linking dormancy to resistance [11, 14, 31, 32] means that it is critical to be able to easily identify and understand the mechanism parasites use to enter and leave dormancy. We have recently demonstrated that pyruvate metabolism and fatty acid synthesis pathways in the apicoplast remain active in dormant parasites. This was supported by active transcription of genes encoding key enzymes in these pathways and inhibitors of these pathways delayed recovery of dormant parasites [22] . We have now further demonstrated that mitochondrial activity is present in dormant parasites and is critical for the recovery of dormant parasites. Our data suggest that only parasites with MMP are able to resume growth, providing a good biomarker for dormant parasites.
The first approach examined the MMP of parasites after DHA treatment using RH staining. RH is an indicator of MMP and only stains live parasites [27] . We observed that RH-stained parasite density declines rapidly from a pretreatment level of 3.3% to a mean of 0.02%. This small population, which is 0.9% of the total treated parasite population, persisted between days 2 and 12 before increasing rapidly with parasite recovery. This indicates that MMP persists in only a small subset (<1%) of parasites after exposure to DHA. This proportion is comparable to the recovery rate reported by Teuscher et al [9] . Interestingly, of this persisting population, approximately 50% of parasites retained MMP (RH positive). In contrast, this persisting RH-positive population was not observed in parasites treated with high doses of ATQ where no parasite regrowth was observed. ATQ is known to inhibit electron transport in the parasites' mitochondria. causing death [21] , thus providing a good negative (dead) control. The fact that ATQ-treated parasites did not stain with RH at 72 hours after treatment indicated that there were no persisting dormant parasites after ATQ treatment, evidenced by no recovery of parasites from the culture. This suggests that the RH-positive population were the "seed" for recovery after DHA treatment. A similar pattern was observed in ARTA-and AS-treated parasites, suggesting that this subset of parasites with MMP persists after treatment with artemisinin class drugs.
The second approach was the recovery experiments, wherein DHA-treated parasites were sorted and then cultured to see whether they could regrow. This experiment clearly showed that parasites retaining MMP (RH positive) resumed growth at 10 000/well, whereas those that lost MMP (RH-negative/ SG positive) failed to recover even at the higher concentration of 5 000 000/well. This demonstrates that only RH-positive parasites are truly dormant parasites, with the ability to regrow. The recovery rate of RH-positive parasites on day 2 after DHA treatment was estimated to be at a minimum of 1/ 10 000 (0.01%) because all of the 10 000/well parasite cultures recovered to 10% parasitemia. This rate is lower than that reported elsewhere [9] . In addition, the time taken for these cultures to reach 10% (25 days) was longer than that required for the unsorted (16 days; Figure 1A ) or for dormant parasites (19 days) from earlier experiments [32] . This delay in regrowth could be due to deleterious effect of staining [33] and the sorting process on the parasites, which can take up to 4 hours, and during this time the dormant parasites are in PBS at room temperature. Furthermore, the actual sorting through the FACS Aria cell sorter can cause damage to the sorted cells. On slides made from the sorted parasites, there was evidence of damage to the parasitized red blood cells, which would affect viability and reduce rates of recovery.
The third approach was to assess whether a mitochondrial inhibitor could suppress mitochondrial activity in dormant parasites and prevent their recovery. When ATQ was added to DHA-treated parasites at lower concentrations, it delayed the parasite recovery by up to 6 days. At ×100 IC 90 , ATQ stopped the regrowth of dormant parasites. Our previous research showed that treatment with mefloquine after DHA treatment was able to slow the regrowth of dormant parasites. The exact mechanism of mefloquine's action on dormant parasites is not clear.
The fourth approach was measuring transcription levels of several genes associated with the mitochondria and apicoplast in RH-positive and RH-negative parasites. Transcripts of 3 mitochondrial genes involved in the electron transport and 2 apicoplast genes were detected in RH-positive parasites. This was not surprising because there is good evidence that together these 2 organelles provide the metabolic activity required for parasite growth and development during the ring stage [19, 20] . However, this is in sharp contrast to RH-negative/SGpositive parasites, in which no transcription of these genes was detected. It is likely that mitochondrial activities provide energy to maintain the viability of dormant parasites and power their recovery.
RH staining also provided an excellent means to determine the morphological characteristics of DHA-induced dormant parasites. Our data show that RH-positive parasites looked like the "pyknotic" forms described by Teuscher [9] and Tucker et al [10] , not morphologically typical ring-stage parasites. In addition, the parasites showed small compact mitochondria as opposed to the branched mitochondrial staining patterns of untreated rings reported by van Dooren et al [34] . In contrast to RH, although SG staining has been used effectively to evaluate parasitemia of P. falciparum [35] , we found that SG cannot distinguish between live and dead parasites because the number of SG-positive parasites decreases much more slowly after DHA treatment, compared with RH-positive parasites, presumably after DNA decays in dead parasites. These experiments used W2 parasites but the techniques have worked on several parasite strains. Should further studies on resistance and dormancy be undertaken, other strains and indeed a variety of strains will need to be used.
Combined, these approaches demonstrated that a small subset of parasites maintained MMP and maintained transcription of key enzymes in the mitochondria and apicoplast after exposure to artemisinin class compounds. This subset of parasites was identifiable by RH staining and was responsible for recovery from dormancy. Inhibiting mitochondrial activity after DHA treatment can kill dormant parasites preventing recovery. These findings not only help to understand the dormancy phenomenon that parasites use to escape artemisinin drug pressure but also provide a means for identifying and purifying dormant parasites after artemisinin treatment. This will greatly enhance our ability to undertake more detailed studies of this parasite stage and may lead to new avenues for better targeting this "sleeping beauty" of P. falciparum and improving the efficacy of artemisinin.
Notes
